Nuzenio

Novartis Pluvicto Fda

Novartis Pluvicto Fda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Novartis (SWX:NOVN) FDA Approval Puts Pluvicto Value Story Back In Focus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 19:48:53 GMT FDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - BenzingaBenzinga · Mon, 03 Aug 2026 16:56:48 GMT Recon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPSRAPS · Mon, 03 Aug 2026 16:51:00 GMT FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints NewsEndpoints News · Mon, 03 Aug 2026 15:26:00 GMT Novartis Pluvicto FDA approval doubles mHSPC patient pool - scanx.tradescanx.trade · Mon, 03 Aug 2026 15:07:31 GMT Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 12:33:04 GMT Novartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVEPMLiVE · Mon, 03 Aug 2026 11:55:35 GMT FDA approves expanded indication for Pluvicto - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 07:30:35 GMT

Timeline

Sun, 09 Aug 2026 19:48:53 GMTNovartis (SWX:NOVN) FDA Approval Puts Pluvicto Value Story Back In Focus - simplywall.st

Mon, 03 Aug 2026 16:56:48 GMTFDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - Benzinga

Mon, 03 Aug 2026 16:51:00 GMTRecon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPS

Mon, 03 Aug 2026 15:26:00 GMTFDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints News

Mon, 03 Aug 2026 15:07:31 GMTNovartis Pluvicto FDA approval doubles mHSPC patient pool - scanx.trade

Mon, 03 Aug 2026 12:33:04 GMTNovartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce Pharma

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Pluvicto16 live mentions FDA12 live mentions Novartis11 live mentions PSMA6 live mentions SWX4 live mentions NOVN4 live mentions Expanded Prostate Cancer4 live mentions Novartis Wins FDA3 live mentions Approval3 live mentions FDA Approval Puts2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Novartis Pluvicto Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.